Results for "Understanding Pharmaceutical Distribution"
HDA Statement on the Confirmation of Robert F. Kennedy, Jr. As HHS Secretary
HDA released a statement on the confirmation of Robert F. Kennedy, Jr., to lead the U.S. Department of Health and Human Services.
HDA Research Foundation Announces 2025 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation announced four recipients of the Karen J. Ribler Scholarship at its Seventeenth Annual CEO Roundtable Fundraiser in Washington, D.C.
HDA Testifies at House Hearing on Healthcare Affordability
Today, HDA President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Health Subcommittee at a hearing on “Lowering Healthcare Costs: Examining the Healthcare Supply Chain.”
HDA Statement on PREVENT Pandemics Act
The Healthcare Distribution Alliance (HDA) released a statement on the inclusion of the PREVENT Pandemics Act (Prepare for a Respond to Existing Viruses, Emerging New Threats, and Pandemics Act), as part of the Consolidated Appropriations Act.
Distributors Leading Efforts to Maintain Supply Chain Integrity
While the impact of the COVID-19 pandemic continues to unfold, distributors are taking proactive steps and working closely with the broader healthcare community to respond to the crisis and prevent disruptions to the pharmaceutical supply chain. As the logistics experts of healthcare, our commitment is to ensure that providers, pharmacies and the patients they serve have access to the vital medicines and supplies they need during these challenging times.